HEPATOLOGÍA EXPERIMENTAL Y VECTORIZACIÓN DE FÁRMACOS
HEVEFARM
Universidade de Santiago de Compostela
Santiago de Compostela, EspañaPublicaciones en colaboración con investigadores/as de Universidade de Santiago de Compostela (8)
2023
-
Mitochondrial RNA methyltransferase TRMT61B is a new, potential biomarker and therapeutic target for highly aneuploid cancers
Cell Death and Differentiation, Vol. 30, Núm. 1, pp. 37-53
-
The outcome of boosting mitochondrial activity in alcohol-associated liver disease is organ-dependent
Hepatology (Baltimore, Md.), Vol. 78, Núm. 3, pp. 878-895
2022
-
Metabolic-associated fatty liver disease: From simple steatosis toward liver cirrhosis and potential complications. Proceedings of the Third Translational Hepatology Meeting, organized by the Spanish Association for the Study of the Liver (AEEH)
Gastroenterologia y Hepatologia, Vol. 45, Núm. 9, pp. 724-734
2021
-
Neddylation inhibition ameliorates steatosis in NAFLD by boosting hepatic fatty acid oxidation via the DEPTOR-mTOR axis
Molecular Metabolism, Vol. 53
2009
-
Bile acids: Chemistry, physiology, and pathophysiology
World Journal of Gastroenterology, Vol. 15, Núm. 7, pp. 804-816
-
In vitro inhibition of OATP-mediated uptake of phalloidin using bile acid derivatives
Toxicology and Applied Pharmacology, Vol. 239, Núm. 1, pp. 13-20
-
Protective effect of bile acid derivatives in phalloidin-induced rat liver toxicity
Toxicology and Applied Pharmacology, Vol. 239, Núm. 1, pp. 21-28
2003
-
Effect of ursodeoxycholic acid on the impairment induced by maternal cholestasis in the rat placenta-maternal liver tandem excretory pathway
Journal of Pharmacology and Experimental Therapeutics, Vol. 305, Núm. 2, pp. 515-524